Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04349969 |
| Title | Phase 1, Dose Escalation and Dose Expansion Study of AK117, a CD47-targeting Antibody |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Akeso |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Blacktown Hospital | Sydney | New South Wales | Australia | Details | ||
| ICON Cancer Foundation | South Brisbane | Queensland | Australia | Details | ||
| Ashford Cancer Centre Research | Kurralta Park | South Australia | Australia | Details | ||
| Austin Health | Heidelberg | Victoria | Australia | Details |